From lab bench to market - Critical issues in tissue engineering

被引:83
作者
Naughton, GK [1 ]
机构
[1] Adv Tissue Sci Inc, La Jolla, CA 92037 USA
来源
REPARATIVE MEDICINE: GROWING TISSUES AND ORGANS | 2002年 / 961卷
关键词
scaffolds; bioreactors; cryopreservation;
D O I
10.1111/j.1749-6632.2002.tb03127.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Revolutionary advances in tissue engineering are redefining approaches to tissue repair and transplantation through the creation of replacement tissues that remain biointeractive after implantation, imparting physiologic functions as well as structure to the tissue or organ damaged by disease or trauma. 1,2 Over the last decade this field has moved from "science fiction" to "science fact" with the research-oriented acceptance of its potential to regulatory approvals allowing commercial products to be available for use in many countries. The maintenance of tissue integrity, functionality, and viability from cell seeding through product manufacture, shipping, and end-use has been accomplished through innovations in design and scale-up of both tissue growth and preservation processes. These unique systems have enabled the delivery of tissue-engineered products that are uniform inter- and intra-lot, readily available as off-the-shelf products, easy to use, and efficacious. Skin replacement products are the most advanced, with several tissue-engineered wound care materials on the market in the U.S. and in several international communities.(3-5) The potential impact of this field is far broader, offering novel solutions to the medical field for drug screening and development, genetic engineering, and total tissue and organ replacement.
引用
收藏
页码:372 / 385
页数:14
相关论文
共 50 条
[31]   Growing new organs [J].
Mooney, DJ ;
Mikos, AG .
SCIENTIFIC AMERICAN, 1999, 280 (04) :60-65
[32]  
Naughton G, 1997, ARTIF ORGANS, V21, P1203
[33]  
Naughton G, 1999, SCI AM, V280, P84
[34]   An industry imperiled by regulatory bottlenecks [J].
Naughton, G .
NATURE BIOTECHNOLOGY, 2001, 19 (08) :709-710
[35]  
Naughton G.K., 1997, SYNTH BIODEGRAD POLY, P121, DOI [10.1007/978-1-4612-4154-6_7, DOI 10.1007/978-1-4612-4154-6_7]
[36]  
Naughton Gail K., 1996, P265
[37]  
Papadaki M, 1998, AM J PHYSIOL-HEART C, V274, pH616
[38]  
Parenteau N, 1999, SCI AM, V280, P83
[39]   EFFECTS OF CYCLIC HYDROSTATIC-PRESSURE ON PROTEOGLYCAN SYNTHESIS IN CULTURED CHONDROCYTES AND ARTICULAR-CARTILAGE EXPLANTS [J].
PARKKINEN, JJ ;
IKONEN, J ;
LAMMI, MJ ;
LAAKKONEN, J ;
TAMMI, M ;
HELMINEN, HJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 300 (01) :458-465
[40]  
PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294